Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
McClellan Mark B. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Mark B. McClellan received an equity award of 13,096 restricted stock units of Common Stock. These units were granted at no cash cost and will vest on the one-year anniversary of the grant date, provided he continues serving on the Board of Directors. After this grant, he holds 370,531 shares directly, reflecting routine, compensation-related equity alignment with shareholders rather than an open-market purchase.
McCarthy Margaret M reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Margaret M. McCarthy reported receiving a grant of 14,273 restricted stock units (RSUs), each representing one share of common stock. All RSUs will vest on the one-year anniversary of the grant date if she continues serving on the Board of Directors. Following this award, she directly holds 144,441 shares. She has elected to defer receipt of the underlying shares until she separates from service as a director or a change of control of the company occurs.
KOSECOFF JACQUELINE B reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Jacqueline B. Kosecoff reported an equity grant of 13,096 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash cost to her as a standard grant, not an open-market purchase.
Each restricted stock unit represents one share of Common Stock and will fully vest on the one-year anniversary of the grant date, assuming she continues to serve on the Board of Directors through that date. Following this grant, she directly holds 303,963 shares, including the new award.
KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Joseph S. Konowiecki received a grant of 24,868 restricted stock units, each representing one share of common stock. These RSUs will fully vest on the first anniversary of the grant date, provided he continues serving on the Board. He has elected to defer receipt of the underlying shares for three years, or earlier upon separation of service or a change of control. Following this award, he holds 1,081,009 shares directly.
JORDEN YON reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare director Jorden Yon received a new equity grant. The filing shows an award of 13,096 restricted stock units of Alignment Healthcare, Inc. common stock, with no cash paid per share. After this grant, Yon directly holds 105,830 shares or share equivalents.
Each of the 13,096 restricted stock units represents a right to receive one share of common stock. The entire grant will vest on the one-year anniversary of the grant date, as long as Yon continues serving on the Board of Directors through that date.
HODGSON DAVID C reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare reported an equity award linked to director David C. Hodgson. The filing shows a grant of 18,982 restricted stock units, each representing one share of common stock, bringing the reported post‑grant balance to 173,408 shares.
The restricted stock units are scheduled to vest on the one-year anniversary of the grant date as long as Hodgson continues serving on the Board of Directors through that date. He has elected to defer receipt of the underlying shares until separation of service as a director, or earlier if there is a change of control of the company.
The award is held solely for the benefit of General Atlantic Service Company, L.P., and Hodgson disclaims beneficial ownership of both the restricted stock units and the underlying common stock. This indicates the economic interest is attributed to the affiliated entity rather than to him personally.
BILNEY JODY L reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Jody L. Bilney received a grant of 16,039 restricted stock units on March 13, 2026. Each unit represents one share of common stock and will vest on the one-year anniversary of the grant date if she continues serving on the board. Bilney has elected to defer delivery of the shares until separation from service or an earlier change of control of the company. Following this award, she holds 129,267 shares of common stock directly.
Alignment Healthcare, Inc. notice of proposed sale: a Form 144 filed reporting planned sales of Common Stock by Hyong (Ken) Kim under a Rule 10b5-1 trading plan. The filing lists two lots acquired on 03/13/2024 (35,000 shares) and 03/13/2025 (19,355 shares).
The filing also discloses recent dispositions within the prior three months: $352,356.88 for 16,506 shares sold on 01/06/2026 and $237,919.52 for 12,694 shares sold on 12/29/2025. The notice identifies a Rule 10b5-1 plan as the sale mechanism.
Alignment Healthcare, Inc. filed a Form 144 reporting proposed sales of Common Stock by an affiliate. The filing lists 25,000 shares acquired upon vesting of restricted stock units on 03/13/2024 and 13,226 shares acquired upon vesting of restricted stock units on 03/13/2025. The securities are identified as shares held at a brokerage account at E-Trade Finance and were granted under the issuer's 2021 Equity Incentive Plan.
Alignment Healthcare, Inc. (ALHC) director Christopher Joyce filed a Form 144 reporting proposed sales of 32,500 shares and 18,818 shares that were acquired upon RSU vesting on 03/13/2024 and 03/13/2025, respectively. The filing notes prior open-market dispositions under a 10b5-1 Sales Plan, showing sales of 10,611 shares on 01/02/2026 for $212,590.32 and 16,187 shares on 12/29/2025 for $303,388.01.